FDA approves 2 Hepatitis C drugs for use in pediatric patients
from Pharmacy Times
The FDA approved supplemental applications for Sovaldi and Harvoni, marketed by Gilead Sciences Inc., to treat hepatitis C virus in pediatric patients. Both drugs were previously approved to treat HCV in adults, but the latest approval expands use to include children aged 12 to 17.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063